SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-143065
Filing Date
2022-05-06
Accepted
2022-05-06 08:24:23
Documents
76
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d345909d10q.htm   iXBRL 10-Q 1491630
2 EX-31.1 d345909dex311.htm EX-31.1 10131
3 EX-31.2 d345909dex312.htm EX-31.2 10204
4 EX-32 d345909dex32.htm EX-32 4504
10 GRAPHIC g345909g0128081534663.jpg GRAPHIC 5673
  Complete submission text file 0001193125-22-143065.txt   6649192

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vivo-20220331.xsd EX-101.SCH 52263
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vivo-20220331_cal.xml EX-101.CAL 48173
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vivo-20220331_def.xml EX-101.DEF 247697
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20220331_lab.xml EX-101.LAB 372600
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20220331_pre.xml EX-101.PRE 339927
70 EXTRACTED XBRL INSTANCE DOCUMENT d345909d10q_htm.xml XML 1221810
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-14902 | Film No.: 22898929
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences